TOP STORIES
Supermarket chain Safeway spent about $350 million to build clinics in more than 800 stores that would offer Theranos’ blood tests. Looks like that deal has now fizzled and that partnership will officially begin to dissolve. — Wall Street Journal
Carly Fiorina is the latest Republican to blame the pharmaceutical industry for rising healthcare prices. She lashed out against drug companies and health insurers in her attack on Obamacare during Tuesday’s debate. — The Hill
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Two more IPOs. Two more mixed results. WaVe Life Sciences hit its per share price and sold more shares than it thought. Voyager Therapeutics, meanwhile, was a little short of its target (but also sold more shares than planned). – Xconomy
Amplyx says it has closed on $40.5 million in Series B financing, and plans to use the capital to advance development of a new anti-fungal compound for treating life-threatening fungal infections. — Xconomy
Hereditary Disease Foundation’s “Celebration of Discovery” benefit and symposium raises $1.2 million to fight Huntington’s disease and other brain disorders. — Hereditary Disease Foundation
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Quest Diagnostics will acquire Clinical Laboratory Partners’ outreach laboratory service business in Connecticut. — Quest
Kristen Kosofsky, formerly managing director at Horizon Technology Finance, is a new Senior Managing Director in the Life Sciences Group at Hercules Technology Growth Capital’s Boston Office. – Business Wire
FDA granted marketing approval to Cotellic to treat malignant melanoma patients in combination with Zelboraf. The Genentech unit of Roche has rights to Cotellic from Exelixis. — BioCentury
The sale of a generic version of Nexium made by Dr. Reddy’s Laboratories Ltd. has been blocked in court by AstraZeneca because of trademark issues concerning its purple color. — Wall Street Journal
PAYERS-PROVIDERS
The Sequoia Project and the Care Connectivity Consortium (CCC) announced the results of a multi-year effort to examine best practices for patient matching for health information exchange partners. Organizations are urged to read the paper provide feedback by late January, 2016. — The Sequoia Project
Health eVillages is supplying newly trained anesthesiology professionals with dozens of mobile medical content devices in East Africa. — Health eVillages
Heal, an on-demand service for doctor house calls, announced that it is now in-network with Anthem Blue Cross of California. — Heal
TECH
Dr. John Sotos, a cardiologist and worldwide medical director at Intel, thinks mobile health is the key to defeating what he calls “the worst disease in the world” – hypertension. — mobihealthnews
According to a study released today by Infinite Convergence Solutions, Inc., 92 percent of healthcare institutions are using non HIPAA-compliant messaging apps. — HIT Consultant
POLITICS
The Senate Health Committee will hold a hearing for President Obama’s nominee to be FDA commissioner next week. — The Hill
The Senate parliamentarian has ruled that defunding Planned Parenthood can be part of a special Republican package repealing parts of ObamaCare. — The Hill
A LITTLE BIT EXTRA
While the fight is certainly not over yet for those against whales in captivity, SeaWorld announced that starting next year it will no long have live orca shows. SeaWorld has received a lot of backlash since the release of the documentary titled Blackfish. — IFLScience
Photo: Flickr user Mike Mozart
